Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Riikka Huuhtanen"'
Autor:
Veera V. Salminen, Eila Lantto, Tuija Poussa, Raija Kallio, Maija Lavonius, Raija Ristamäki, Markus J. Mäkinen, Eija Pääkkö, Jari Sundström, Eetu Heervä, Sirpa Leppä, Johanna Mattson, Ari Ristimäki, P.J. Osterlund, Arno Nordin, Eija Sutinen, Eija Korkeila, T. Salminen, Kaisa Lehtomäki, Aki Uutela, P. Ryymin, Irina Rinta-Kiikka, Riikka Huuhtanen, Ali Ovissi, Olli Carpén, Marjut Timonen, Jani Saunavaara, Nina Lundbom, Heikki Mäkisalo, A.I. Hakkarainen, P. Halonen, Eveliina Lammentausta, Annika Ålgars, Helena Isoniemi, Johanna Virtanen, L. M. Soveri, R. Blanco Sequeiros, Nieminen Lasse, Niina Paunu, Heidi Penttinen, E. Liukkonen, Petri Bono, Siru Mäkelä, Martine Vornanen, Emerik Osterlund, Juhani Kosunen
Publikováno v:
ESMO Open
Background Colorectal cancer liver metastases respond to chemotherapy and targeted agents not only by shrinking, but also by morphologic and metabolic changes. The aim of this study was to evaluate the value of advanced magnetic resonance imaging (MR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f9ddcc105fe6b21373dbe71abb69349
http://urn.fi/urn:nbn:fi-fe2022030221470
http://urn.fi/urn:nbn:fi-fe2022030221470
Autor:
Meri Utriainen, T. Wigren, Raija Asola, Tuomo Alanko, Seppo Pyrhönen, P-L Kellokumpu-Lehtinen, Liisa Sailas, Heikki Joensuu, Riikka Huuhtanen, Petri Bono, M. Hahka-Kemppinen, R. Kokko, Kaisa L. Sunela, Taina Turpeenniemi-Hujanen, M. Leinonen
Publikováno v:
Annals of Oncology
Background: Alternating administration of docetaxel and gemcitabine might result in improved time-to-treatment failure (TTF) and fewer adverse events compared with single-agent docetaxel as treatment of advanced breast cancer. Patients and methods: W
Autor:
Carl Blomqvist, Pekka Virkkunen, Sirpa Asko-Seljavaara, Erkki Tukiainen, Martti Virolainen, Pentscho Popov, Riikka Huuhtanen
Publikováno v:
Plastic and Reconstructive Surgery. 113:222-230
The objective of this retrospective follow-up study was to evaluate the outcome of patients with soft-tissue sarcoma treated by the authors' protocol, which consists of a selective combination of conservative surgery and radiotherapy. Patients who re
Publikováno v:
Surgical endoscopy. 29(9)
We compared oncologic and surgical outcome between minimally invasive esophagectomy (MIE) and the Ivor Lewis-type open approach (OE) in the treatment of locally advanced esophageal adenocarcinoma (EAC).Of 284 patients undergoing surgery for EAC betwe
Autor:
Riikka Huuhtanen, Petrus Järvinen, Heikki Järvinen, Anna Lepistö, Merja Aronen, Jonas Kantonen, Ari Ristimäki
Publikováno v:
International journal of colorectal disease. 29(8)
Patients with pseudomyxoma peritonei (PMP) benefit from cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Reports on this modality usually have included only patients with successful HIPEC treatment, which can potenti
Publikováno v:
Duodecim; laaketieteellinen aikakauskirja. 130(6)
Treatment of choice for esophageal cancer requires multidisciplinary collaboration and requires careful assessment of the stage of the tumor and the patient's condition. When the cancer has extended or if the patient will not tolerate burdensome trea
Publikováno v:
British Journal of Cancer
In many malignant diseases the expression levels of CD44 and its splice variant v6 (CD44v6) have been associated with the prognosis. The purpose of this study was to investigate the clinical significance of CD44 in adult soft tissue sarcomas (STS). 1
Autor:
S. Asko-Seljaavaara, Martti Virolainen, Carl Blomqvist, Pentscho Popov, Erkki Tukiainen, Pekka Virkkunen, Riikka Huuhtanen
Publikováno v:
European Journal of Surgical Oncology. 26:679-685
Aims The aims of this retrospective follow-up study were to evaluate the justification for limb-saving multi-disciplinary treatment of soft tissue sarcomas (STS) and to report the results achieved by our treatment protocol. Local control was studied,
Autor:
Martti Virolainen, Leif C. Andersson, Riikka Huuhtanen, Tom Böhling, Tom Wiklund, Bernhard Tribukait, Carl Blomqvist
Publikováno v:
British Journal of Cancer
A small but not insignificant number of patients experience a prolonged survival after treatment of metastatic soft tissue sarcoma. This must be weighed against the majority of the patients who benefit little from the therapy, but nevertheless experi
Autor:
Sirpa Asko-Seljavaara, Erkki Tukiainen, Mauri Lepäntalo, Maija Tarkkanen, Riikka Huuhtanen, Martti Virolainen, Sakari Knuutila, Tom Wiklund, Inkeri Elomaa
Publikováno v:
Genes, Chromosomes and Cancer. 25:323-331
The aims of the present study were to compare genetic aberrations in primary sarcomas and their pulmonary metastases and to explore the pathways associated with disease spreading. The primary tumor and its subsequent pulmonary metastasis of 22 patien